drugset / Trial / NCT02857842

Corticosteroid Reduction in COPD

NCT02857842 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This study explores whether patients hospitalized with chronic obstructive pulmonary disease (COPD) exacerbation may have fewer days with prednisolone and with the same treatment effect by controlling the treatment by daily measurements of eosinophils.

Timeline

Start
2016-08
Primary completion
2018-09
Completion
2019-01

Outcome

Met primary endpoint

paper INTERPRETATION: Eosinophil-guided therapy was non-inferior compared with standard care for the number of days alive and out of hospital PMID 31122894 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 37.5 mg Oral